Perturbations in prostate architecture, as seen in benign prostatic hyperplasia (BPH), prostatitis, or prostate cancer (PCa), cause elevated PSA levels, aiding diagnostic stratification. The gene discussed is KLK3; the disease is prostate carcinoma.